Clinical trial
Study of U101 for Bladder Pain and/or Urgency
NCT00256542 · Urigen, Industry · Completed
Key facts
| NCT number | NCT00256542 |
|---|---|
| Title | Study of U101 for Bladder Pain and/or Urgency |
| Official title | A Phase II Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravesical Alkalinized Lidocaine-Heparin for the Symptoms of Pelvic Pain and/or Urgency of Bladder Origin |
| Lead sponsor | Urigen, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pelvic Pain, Interstitial Cystitis, Bladder Diseases |
| Intervention type | Drug |
| Interventions | Alkalinized Lidocaine-Heparin |
| Enrollment | 90 |
| Start date | Jan 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Nov 21, 2005 |
| Last update posted | Sep 29, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: